NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read here
See how UMR members are aiding in the fight against the coronavirus here
A new episode of the Amazing Things Podcast is now available! Check it out here.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Becton Dickson is the NJ-based syringe manufacturer that stepped up to take on COVID-19

In the early stages of the COVID pandemic, as most of the world sought hope amid soaring death tolls and sinking economies, a New Jersey company looked ahead and readied itself for the moment when a medical solution would arrive. Anticipating the development of vaccines as well as a red-hot worldwide demand for its products, Becton Dickinson, the world′s leading syringe manufacturer, ramped up production at plants in the U.S., Asia, and Europe early in 2020. Hundreds of millions of orders poured in from across the globe and in response, the Franklin Lakes-based company produced 1 billion more needles and syringes than in a typical year, an increase of more than 2,000 a minute.